#Zolgensma #Zolgensma #Zolgensma

Zolgensma Approved!

AveXis, a Novartis company, has received FDA approval for Zolgensma.

Learn MoreLearn More

The 2019 Annual SMA Conference Booklet is Now Posted Online

The 2019 Annual SMA Conference booklet is

READ MORE

Family Friendly Research Poster Session Presenters Announced

Family Friendly Research Poster Session Presenters Announced

The Family Friendly Research Poster Session will be held on Saturday, June 29th from 6:30pm to 8:00pm at the 2019 Annual SMA...

READ MORE

Biogen Issues Q2 Community Statement on Spinraza

Biogen Issues Q2 Community Statement on Spinraza

Dear members of the SMA community,

We are grateful for the opportunity to continue to help support individuals with spinal muscular...

READ MORE

Team Cure SMA Celebrates Global Running Day!

Team Cure SMA Celebrates Global Running Day!

Happy Global Running Day! Is Global Running Day a made-up holiday? Kind of. But unlike other made-up holidays dedicated to eating pancakes or...

READ MORE

Scholar Rock Announces Positive Final Results from Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers

Scholar Rock Announces Positive Final Results from Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers

Scholar Rock

READ MORE

© 2019 Cure SMA | Cure SMA is recognized as tax-exempt under section 501(c)(3) of the Internal Revenue Code. EIN: 36-3320440. | Privacy Policy

Powered by Blackbaud
nonprofit software